KRAS and cancer: Intriguingly, despite having significantly high network scores, some well-established oncogenes and tumour suppressors, like KRAS, TP53, PTEN, MYC, EGFR, MDM2 and BRCA1, did not fall among the top-50 scoring genes shared by the cancers analysed.